Effect of nicotinic adic on the composition of high density lipoprotein (HDL) and endothelial function in patients with premature coronary heart disease and elevated HDL-cholesterol.
Phase of Trial: Phase IV
Latest Information Update: 16 Feb 2013
At a glance
- Drugs Nicotinic-acids (Primary)
- Indications Hypercholesterolaemia; Ischaemic heart disorders
- Focus Therapeutic Use
- 25 Jan 2013 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 14 Jan 2013 Planned end date changed from 1 Mar 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
- 14 Jan 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.